IPO Price History
Closed
Avience Biomedicals Ltd. logo

Avience Biomedicals Ltd. IPO

SME IPOListedAVIENCENSE SME
Current Market Price (CMP)
₹240(+15.38%)
Sector: Hospital & Healthcare Services
Current Price (CMP)
₹240(+15.38%)

Live Market Quote

Listing Price & Gain
₹414.95(+99.50%)

Day 1 Exchange Open

IPO Issue Price
₹208

Band: ₹196 - ₹208

Total Subscription
355.06x

Overall Bid Demand

Total Issue Size
₹28.53 Cr

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
18 Jun 2026
IPO Bidding Closes
22 Jun 2026
Allotment & Refunds
23 Jun 2026
Exchange Listing Day
25 Jun 2026

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 355.06x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)0x
Non-Institutional Investors (NII / HNI)0x
Retail Individual Investors (RII)—
Total Subscription355.06x
Updated as on 22-Jun-2026 18:06:00

Listing Day & Return Performance

Listing Day Gain+99.50%
₹208 (Issue) → ₹414.95 (List)
Per share profit: +₹206.95
Holding Return (Till Date)+15.38%
₹208 (Issue) → ₹240 (CMP)
Net gain per share: +₹32.00
Post-Listing Performance (Listing Day → Today):-42.16%

About Avience Biomedicals Ltd. IPO

Avience Biomedicals Ltd. is an Indian public offering categorized under the SME (Small and Medium Enterprise) segment. The public issue opened for bidding on 18 Jun 2026 and concluded on 22 Jun 2026, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹196 - ₹208. The aggregate issue size was approximately ₹28.53 crore. The company operates primarily within the Hospital & Healthcare Services sector.

During the bidding window, Avience Biomedicals Ltd. witnessed heavy demand with an overall subscription of 355.06 times. Institutional investors (QIB) subscribed —, non-institutional high-net-worth investors (NII) subscribed —, and retail individual investors (RII) bid — their reserved quota.

The equity shares of Avience Biomedicals Ltd. officially debuted on the stock exchanges on 25 Jun 2026 at an opening listing price of ₹414.95, delivering a listing day return of +99.50% (premium) over the final issue price. As per the latest market data, the stock trades at ₹240, representing an overall gain of +15.38% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Avience Biomedicals Ltd. IPO?
The issue price of Avience Biomedicals Ltd. IPO was fixed at ₹208 per equity share. The indicative bidding price band was ₹196 - ₹208.
What was the total issue size of Avience Biomedicals Ltd. IPO?
The total issue size of Avience Biomedicals Ltd. IPO was approximately ₹28.53 crore.
What were the open, close, and listing dates for Avience Biomedicals Ltd. IPO?
Avience Biomedicals Ltd. IPO opened on 18 Jun 2026, closed on 22 Jun 2026, listed on 25 Jun 2026.
How much was Avience Biomedicals Ltd. IPO subscribed?
The IPO received an overall subscription of 355.06 times. Category-wise, QIBs subscribed —x, NIIs subscribed —x, and Retail investors subscribed —x.
What was the listing price and listing gain of Avience Biomedicals Ltd. IPO?
Avience Biomedicals Ltd. IPO listed on the stock exchange at ₹414.95, delivering a listing gain of 99.50% compared to the IPO issue price of ₹208.
Is Avience Biomedicals Ltd. IPO a Mainboard or SME IPO?
Avience Biomedicals Ltd. IPO is a SME IPO listed on the SME platform of NSE SME.
What is the current return of Avience Biomedicals Ltd. IPO since its IPO?
At the latest market quote of ₹240, Avience Biomedicals Ltd. IPO has generated an all-time return of +15.38% since its initial public offering.

Related SME IPOs (2026)

SAIURJA
Sai Urja Indo Ventures Ltd.
₹113+18.41%
SKOFFSET
S.K.Offset Ltd.
₹125+0.80%
HNIL
Himalaya Nutravedics India Ltd.
₹106+11.32%
ANAND
Anand Seamless Ltd.
₹72+0.14%